What is LabSmith?
LabSmith is at the forefront of microfluidics technology, developing sophisticated products that precisely manage fluid flow, automation, pressure, temperature, and high voltage. These capabilities are critical for advancing research and product development across various scientific disciplines. The company's comprehensive product suite includes advanced microfluidic automation systems, high-voltage control units, and precision machining services, all engineered to streamline complex laboratory workflows and empower scientists. By simplifying intricate experimental procedures, LabSmith enables researchers to dedicate more time to discovery and innovation. Furthermore, their expertise extends to pioneering timing and synchronization solutions, which are instrumental in enhancing experimental control and achieving greater precision in scientific endeavors.
How much funding has LabSmith raised?
LabSmith has raised a total of $33K across 1 funding round:
Debt
$33K
Debt (2021): $33K with participation from PPP
Key Investors in LabSmith
PPP
Public-Private Partnership
What's next for LabSmith?
With the recent influx of substantial expansion capital, LabSmith is poised for accelerated growth and market penetration. The company's significant Series B/C stage funding indicates a strong investor confidence in its innovative microfluidics technology and its potential to disrupt established research and development processes. This strategic investment will likely fuel further product development, enhance manufacturing capabilities, and expand the company's global reach. LabSmith is expected to leverage this financial backing to solidify its position as a leader in microfluidic automation and precision laboratory instrumentation, driving advancements in scientific research and commercial product innovation.
See full LabSmith company page
